Voyageur Pharmaceuticals (CVE:VM) Stock Price Up 21.2% – Here’s Why

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) was up 21.2% during trading on Thursday . The stock traded as high as C$0.21 and last traded at C$0.20. Approximately 292,294 shares changed hands during mid-day trading, a decline of 46% from the average daily volume of 538,273 shares. The stock had previously closed at C$0.17.

Voyageur Pharmaceuticals Trading Up 21.2 %

The business has a 50-day moving average price of C$0.10 and a two-hundred day moving average price of C$0.07. The company has a market cap of C$27.89 million, a P/E ratio of -20.00 and a beta of 0.32. The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Recommended Stories

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.